33 results
8-K
EX-99.2
LBPH
Longboard Pharmaceuticals, Inc.
1 Aug 24
Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
4:10pm
Bold & experienced leadership with expertise in CNS and rare disorders Pipeline with differentiated PK / PD and target engagement CNS programs
PRE 14A
LBPH
Longboard Pharmaceuticals, Inc.
28 Mar 24
Preliminary proxy
4:36pm
Social Responsibility – Environmental, Social and Governance Initiative
Patient Advocacy
Environmental Sustainability
Employee Culture, Engagement … oversee our corporate accounting and financial reporting processes;
managing the selection, engagement, qualifications, independence and performance
8-K
EX-99.2
2ihzwxkocp
12 Mar 24
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
4:10pm
8-K
EX-99.1
2f20qt
29 Nov 23
Regulation FD Disclosure
8:35am
8-K
EX-99.1
g8m6t
11 Oct 23
Regulation FD Disclosure
9:26am
8-K
EX-3.1
zle7lfcq
22 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:21pm
8-K
EX-99.1
zrkenzno4j43f
5 Dec 22
Regulation FD Disclosure
8:45am
8-K
c6ulho9
5 Dec 22
Regulation FD Disclosure
8:45am
8-K
EX-99.1
tcb0ehwt6mw0r
3 Nov 22
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results
8:46am
DEF 14A
2mbe5o0l a9re34xxmai
13 Apr 22
Definitive proxy
4:15pm
10-K
rmola34n gapq
3 Mar 22
Annual report
4:31pm
8-K
EX-99.1
ot9z6h7jc69yv
10 Jan 22
Regulation FD Disclosure
7:01am
8-K
EX-99.1
z9lrpixj1r2kihj
1 Dec 21
Regulation FD Disclosure
9:01am
8-K
8ievjrzzo1c 9j0cc
8 Sep 21
Regulation FD Disclosure
7:25am
8-K
EX-99.1
amrwns7
8 Sep 21
Regulation FD Disclosure
7:25am